Keywords: DES، استنت (ها) دارو،; chronic total occlusion; drug-eluting stent; percutaneous coronary intervention; prognosisCABG, coronary artery bypass graft surgery; CI, confidence interval; CTO, chronic total occlusion; DES, drug-eluting stent(s); HR, hazard ratio; MI, myocardial infar
مقالات ISI DES، استنت (ها) دارو، (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: DES، استنت (ها) دارو،; drug-eluting stent(s); dual antiplatelet therapy; everolimus; stent thrombosisBMS, bare-metal stent(s); CI, confidence interval; DAPT, dual antiplatelet therapy; DES, drug-eluting stent(s); EES, everolimus-eluting stent(s); HR, hazard ratio; MACCE, major
Keywords: DES، استنت (ها) دارو،; bypass graft; coronary bypass graft surgery; percutaneous coronary interventionCABG, coronary artery bypass graft; CART, Clinical Assessment, Reporting, and Tracking; CI, confidence interval; DES, drug-eluting stent(s); MI, myocardial infarction; NCDR, Na
Keywords: DES، استنت (ها) دارو،; fractional flow reserve; functional optimization; major adverse cardiovascular outcomes; percutaneous coronary intervention; prognosisBMS, bare-metal stent(s); CI, confidence interval; DES, drug-eluting stent(s); FFR, fractional flow reserve; HR, hazard r
Keywords: DES، استنت (ها) دارو،; bioresorbable scaffold; coronary bifurcation; percutaneous coronary interventionBRS, bioresorbable scaffold; DES, drug-eluting stent(s); IVUS, intravascular ultrasound; KBI, kissing balloon inflation; MB, main branch; OCT, optical coherence tomography; PO
Keywords: DES، استنت (ها) دارو،; drug-coated balloon; drug-eluting stent; in-stent restenosisBMS, bare-metal stent(s); CI, confidence interval; DAPT, dual antiplatelet therapy; DCB, drug-coated balloon; DES, drug-eluting stent(s); HR, hazard ratio; ISR, in-stent restenosis; IVUS, intrava
Keywords: DES، استنت (ها) دارو،; bare-metal stent restenosis; drug-eluting stent restenosis; in-stent restenosis; late restenosis; paclitaxel-coated balloonBMS, bare-metal stent(s); BMS-ISR, bare-metal stent restenosis; CI, confidence interval(s); DES, drug-eluting stent(s); DES-ISR, dru
Keywords: DES، استنت (ها) دارو،; coronary artery disease complexity; drug-eluting stent(s); percutaneous coronary intervention; SYNTAX scoreCABG, coronary artery bypass surgery; CAD, coronary artery disease; DES, drug-eluting stent(s); PCI, percutaneous coronary intervention
Keywords: DES، استنت (ها) دارو،; late bleeding; mortality; platelet reactivityDAPT, dual antiplatelet therapy; DES, drug-eluting stent(s); MACE, major adverse cardiac event(s); MI, myocardial infarction; PCI, percutaneous coronary intervention; PDB, post-discharge bleeding; PDMI, post-di
Keywords: DES، استنت (ها) دارو،; clopidogrel; diabetes mellitus; long-term outcomes; percutaneous coronary interventionsBMS, bare-metal stent(s); CABG, coronary artery bypass grafting; CI, confidence interval; DAPT, dual antiplatelet therapy; DES, drug-eluting stent(s); DM, diabetes mell
Keywords: DES، استنت (ها) دارو،; bare-metal stent(s); drug-eluting stent(s); meta-analysis; stent thrombosisBES, biolimus-eluting stent(s); BMS, bare-metal stent(s); CI, credible interval; CoCr-EES, cobalt-chromium everolimus-eluting stent(s); DES, drug-eluting stent(s); HR, hazard ratio
Keywords: DES، استنت (ها) دارو،; bifurcation; clinical outcome; coronary bifurcation lesion; drug-eluting stent; percutaneous coronary interventionCI, confidence interval; DES, drug-eluting stent(s); PCI, percutaneous coronary intervention; POCO, patient-oriented composite outcome; TLF,
Keywords: DES، استنت (ها) دارو،; bioresorbable scaffold; coronary artery disease; optical coherence tomography; thrombosisBVS, bioresorbable vascular scaffold; CAD, coronary artery disease; DAPT, dual antiplatelet therapy; DES, drug-eluting stent(s); IR, infrared; LCX, left circumflex ar
Keywords: DES، استنت (ها) دارو،; left main; stenting technique; SYNTAX scoreCABG, coronary artery bypass graft surgery; DES, drug-eluting stent(s); ISR, in-stent restenosis; LCX, left circumflex coronary artery; LMCA, left main coronary artery; MACE, major adverse cardiac event(s); MI, m
Keywords: DES، استنت (ها) دارو،; animals; bioresorbable scaffold; coronary artery imaging; pathologyBVS, bioresorbable vascular scaffold(s); DES, drug-eluting stent(s); EES, everolimus-eluting stent(s); IVUS, intravascular ultrasound; LA, lumen area; MLD, mean lumen diameter; RLA, refere
Keywords: DES، استنت (ها) دارو،; adverse; coronary stent; post-operative; surgeryBMS, bare-metal stent(s); DES, drug-eluting stent(s); MI, myocardial infarction; RCRI, revised Cardiac Risk Index; RD, risk difference
Keywords: DES، استنت (ها) دارو،; coronary wall shear stress; intracoronary Doppler velocity and pressure; intravascular imaging; myocardial bridge; myotomy; percutaneous coronary interventionBMS, bare-metal stent(s); CABG, coronary artery bypass grafting; DES, drug-eluting stent(s); FFR,
Keywords: DES، استنت (ها) دارو،; bioresorbable scaffold; coronary artery diseaseBRS, bioresorbable scaffold(s); BVS, bioresorbable vascular scaffold; CE, Conformité Européenne; DES, drug-eluting stent(s); IVUS, intravascular ultrasound; MACE, major adverse cardiac event(s); OCT, optical
Keywords: DES، استنت (ها) دارو،; drug-eluting stent(s); intravascular ultrasound; percutaneous coronary interventionBMS, bare-metal stent(s); CI, confidence interval; DES, drug-eluting stent(s); HR, hazard ratio; IVUS, intravascular ultrasound; MACE, major adverse cardiac events; MI, myo
Keywords: DES، استنت (ها) دارو،; drug-eluting stent; malapposition; optical coherence tomography; stent coverageCSA, cross-sectional area(s); DES, drug-eluting stent(s); IVUS, intravascular ultrasound; NIH, neointimal hyperplasia; OCT, optical coherence tomography
Keywords: DES، استنت (ها) دارو،; coronary disease; drug-eluting; imaging; scaffold; stent(s)%DS, percent diameter stenosis; BCS, bioresorbable coronary scaffold; CK, creatine kinase; DES, drug-eluting stent(s); IVUS, intravascular ultrasound; LLL, late lumen loss; MACE, major adverse car
Keywords: DES، استنت (ها) دارو،; coronary artery disease; percutaneous coronary intervention; stent thrombosisACS, acute coronary syndrome(s); ARC, Academic Research Consortium; BMS, bare-metal stent(s); DAPT, dual-antiplatelet therapy; DES, drug-eluting stent(s); GPI, glycoprotein IIb/I
Keywords: DES، استنت (ها) دارو،; drug-eluting stent(s); incomplete stent apposition; intravascular ultrasound; optical coherence tomography; percutaneous coronary intervention; stent malappositionBMS, bare-metal stent(s); DES, drug-eluting stent(s); EES, everolimus-eluting stent(s); ISA,
Angiographic and Clinical Outcomes After Everolimus-Eluting Stenting for Unprotected Left Main Disease and High Anatomic Coronary Complexity
Keywords: DES، استنت (ها) دارو،; everolimus-eluting stent(s); left main disease; percutaneous coronary interventionCABG, coronary artery bypass graft; CTO, chronic total occlusion; DES, drug-eluting stent(s); EES, everolimus-eluting stent(s); EuroSCORE, European system for cardiac operat
1-Year Results of the REMEDEE Registry : Clinical Outcomes After Deployment of the Abluminal Sirolimus-Coated Bioengineered (Combo) Stent in a Multicenter, Prospective All-Comers Registry
Keywords: DES، استنت (ها) دارو،; clinical outcomes; Combo; endothelial progenitor cell; PCI; stentCABG, coronary artery bypass grafting; DAPT, dual antiplatelet therapy; DES, drug-eluting stent(s); MI, myocardial infarction; NSTE-ACS, non–ST-segment elevation acute coronary syndrome(s);
The Impact of Timing of Ischemic and Hemorrhagic Events on Mortality After Percutaneous Coronary Intervention : The ADAPT-DES Study
Keywords: DES، استنت (ها) دارو،; bleeding; drug-eluting stent(s); ischemia; percutaneous coronary intervention; stent thrombosisCB, clinically relevant bleeding; CI, confidence interval; DES, drug-eluting stent(s); HPR, high platelet reactivity; HR, hazard ratio; MI, myocardial infarctio
Overview of the 2016 U.S. Food and Drug Administration Circulatory System Devices Advisory Panel Meeting on the Absorb Bioresorbable Vascular Scaffold System
Keywords: DES، استنت (ها) دارو،; bioresorbable vascular scaffold; U.S. Food and Drug AdministrationBMS, bare-metal stent(s); BVS, bioresorbable vascular scaffold; DES, drug-eluting stent(s); FDA, U.S. Food and Drug Administration; MI, myocardial infarction; PMA, pre-market approval appli
6-Month Versus 12-Month Dual-Antiplatelet Therapy Following Long Everolimus-Eluting Stent Implantation : The IVUS-XPL Randomized Clinical Trial
Keywords: DES، استنت (ها) دارو،; coronary artery disease; drug-eluting stent(s); dual-antiplatelet therapyCI, confidence interval; DAPT, dual-antiplatelet therapy; DES, drug-eluting stent(s); HR, hazard ratio
Drug-Coated Balloons for Revascularization of Infrapopliteal Arteries : A Meta-Analysis of Randomized Trials
Keywords: DES، استنت (ها) دارو،; drug-coated balloon; drug-eluting stent(s); infrapopliteal artery; meta-analysis; plain angioplastyCI, confidence interval; CLI, critical limb ischemia; DCB, drug-coated balloon; DES, drug-eluting stent(s); LLL, late lumen loss; MAE, major adverse event(s
Prevalence and Clinical Impact of Tissue Protrusion After Stent Implantation : An ADAPT-DES Intravascular Ultrasound Substudy
Keywords: DES، استنت (ها) دارو،; coronary artery disease; intravascular ultrasound; tissue protrusionBMI, body mass index; CK, creatine kinase; DES, drug-eluting stent(s); EEM, external elastic membrane; IQR, interquartile range; IVUS, intravascular ultrasound; MACE, major adverse cardia
Long-Term P2Y12-Receptor Antagonists in Post-Myocardial Infarction Patients : Facing a New Trilemma?
Keywords: DES، استنت (ها) دارو،; clopidogrel; platelets; prasugrel; thienopyridines; ticagrelorACS, acute coronary syndrome; DES, drug-eluting stent(s); MACCE, major adverse cardiovascular and cerebrovascular events; MI, myocardial infarction; PCI, percutaneous coronary intervention; STE
1-Year Outcomes of Everolimus-Eluting Bioresorbable Scaffolds Versus Everolimus-Eluting Stents : A Propensity-Matched Comparison of the GHOST-EU and XIENCE V USA Registries
Keywords: DES، استنت (ها) دارو،; bioresorbable scaffolds; drug-eluting stent(s); propensity scoreBRS, bioresorbable scaffold(s); DES, drug-eluting stent(s); DOCE, device-oriented composite endpoint; EES, everolimus-eluting stent(s); PCI, percutaneous coronary intervention
Long-Term Results of Everolimus-Eluting Stents Versus Drug-Eluting Balloons in Patients With Bare-Metal In-Stent Restenosis : 3-Year Follow-Up of the RIBS V Clinical Trial
Keywords: DES، استنت (ها) دارو،; drug-eluting balloon(s); drug-eluting stent(s); everolimus-eluting stent(s); in-stent restenosisBMS, bare-metal stent(s); DEB, drug-eluting balloon(s); DES, drug-eluting stent(s); EES, everolimus-eluting stent(s); ISR, in-stent restenosis
Optimal P2Y12 Inhibitor in Patients With ST-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention : A Network Meta-Analysis
Keywords: DES، استنت (ها) دارو،; angioplasty; clopidogrel; P2Y12 inhibitors; percutaneous coronary intervention; prasugrel; ST-segment elevation myocardial infarction; thienopyridines; ticagrelorACS, acute coronary syndrome(s); DES, drug-eluting stent(s); GPI, glycoprotein IIb/IIIa inhib
Is Bare-Metal Stent Implantation Still Justifiable in High Bleeding Risk Patients Undergoing Percutaneous Coronary Intervention? : A Pre-Specified Analysis From the ZEUS Trial
Keywords: DES، استنت (ها) دارو،; dual antiplatelet therapy; high bleeding risk; zotarolimus-eluting stent(s)BARC, Bleeding Academic Research Consortium; BMS, bare-metal stent(s); CI, confidence interval; DES, drug-eluting stent(s); DAPT, dual antiplatelet therapy; E-ZES, zotarolimus-elut
Safety and Efficacy of New-Generation Drug-Eluting Stents in Women Undergoing Complex Percutaneous Coronary Artery Revascularization : From the WIN-DES Collaborative Patient-Level Pooled Analysis
Keywords: DES، استنت (ها) دارو،; complex PCI; drug-eluting stent(s); outcomes; womenCAD, coronary artery disease; CPCI, complex percutaneous coronary intervention; DES, drug-eluting stent(s); MI, myocardial infarction; PCI, percutaneous coronary intervention; RCT, randomized controlled t
The Impact of Post-Procedural Asymmetry, Expansion, and Eccentricity of Bioresorbable Everolimus-Eluting Scaffold and Metallic Everolimus-Eluting Stent on Clinical Outcomes in the ABSORB II Trial
Keywords: DES، استنت (ها) دارو،; asymmetry; bioresorbable vascular scaffolds; eccentricity; expansionAI, asymmetry index; BVS, bioresorbable vascular scaffold; DES, drug-eluting stent(s); DoCE, device-oriented composite endpoint; EES, everolimus-eluting stent(s); EI, eccentricity index;
Left Main Coronary Artery Disease : Secular Trends in Patient Characteristics, Treatments, and Outcomes
Keywords: DES، استنت (ها) دارو،; clinical decision making; coronary artery bypass; coronary disease; percutaneous coronary intervention; revascularization; stentsBMS, bare-metal stent(s); CABG, coronary artery bypass grafting; CAD, coronary artery disease; DES, drug-eluting stent(s); LMC
Long-Term Efficacy and Safety of Paclitaxel-Eluting Balloon for the Treatment of Drug-Eluting Stent Restenosis : 3-Year Results of a Randomized Controlled Trial
Keywords: DES، استنت (ها) دارو،; balloon angioplasty; drug-eluting stent restenosis; paclitaxel-eluting balloon; paclitaxel-eluting stentBA, balloon angioplasty; CI, confidence interval; DES, drug-eluting stent(s); HR, hazard ratio; MI, myocardial infarction; PEB, paclitaxel-eluting ball
Randomized Comparison of FFR-Guided and Angiography-Guided Provisional Stenting of True Coronary Bifurcation Lesions : The DKCRUSH-VI Trial (Double Kissing Crush Versus Provisional Stenting Technique for Treatment of Coronary Bifurcation Lesions VI)
Keywords: DES، استنت (ها) دارو،; coronary bifurcation lesions; fractional flow reserve; major adverse cardiac events; revascularization; stent thrombosisAngio, angiography; DES, drug-eluting stent(s); DMV, distal main vessel; DS, diameter of stenosis; FFR, fractional flow reserve; KBI, k
Benefits and Risks of Extended Duration Dual Antiplatelet Therapy After PCI in Patients With and Without Acute Myocardial Infarction
Keywords: DES، استنت (ها) دارو،; acute coronary syndromes; antiplatelet therapy; myocardial infarction; percutaneous coronary intervention; randomized clinical trialBMS, bare-metal stent(s); CI, confidence interval; DES, drug-eluting stent(s); HR, hazard ratio; MACCE, major adverse cardi
CABG Versus PCI : Greater Benefit in Long-Term Outcomes With Multiple Arterial Bypass Grafting
Keywords: DES، استنت (ها) دارو،; arterial grafting; coronary stents; myocardial revascularization; propensity matchingBMS, bare-metal stent(s); CABG, coronary artery bypass graft; CAD, coronary artery disease; CI, confidence interval; DES, drug-eluting stent(s); HR, hazard ratio; LAD, le
A Prospective Randomized Trial of Drug-Eluting Balloons Versus Everolimus-Eluting Stents in Patients With In-Stent Restenosis of Drug-Eluting Stents : The RIBS IV Randomized Clinical Trial
Keywords: DES، استنت (ها) دارو،; angiography; percutaneous coronary intervention; proliferation; revascularizationBMS, bare-metal stent(s); DEB, drug-eluting balloon(s); DES, drug-eluting stent(s); EES, everolimus-eluting stent(s); ISR, in-stent restenosis; MI, myocardial infarction; MLD
Short- Versus Long-Term Dual Antiplatelet Therapy After Drug-Eluting Stent Implantation : An Individual Patient Data Pairwise and Network Meta-Analysis
Keywords: DES، استنت (ها) دارو،; bleeding; major adverse cardiac event(s); stent thrombosisACS, acute coronary syndrome(s); CI, confidence interval; CrI, credible interval; DAPT, dual antiplatelet therapy; DES, drug-eluting stent(s); HR, hazard ratio; MACE, major adverse cardiac event(s)
A Prospective Randomized Trial of Everolimus-Eluting Stents Versus Bare-Metal Stents in Octogenarians : The XIMA Trial (Xience or Vision Stents for the Management of Angina in the Elderly)
Keywords: DES، استنت (ها) دارو،; bare-metal stent(s); drug-eluting stent(s); octogenariansBMS, bare-metal stent(s); CVA, cerebrovascular accident; DAPT, dual antiplatelet therapy; DES, drug-eluting stent(s); MI, myocardial infarction; PCI, percutaneous coronary intervention; TVR, target
Hybrid Revascularization for Multivessel Coronary Artery Disease
Keywords: DES، استنت (ها) دارو،; CABG; hybrid revascularization; multivessel coronary artery disease; PCICABG, coronary artery bypass grafting; DES, drug-eluting stent(s); HCR, hybrid coronary revascularization; HPS, HYBRID patency score; LAD, left anterior descending artery; LIMA, left
Short- Versus Long-Term Duration of Dual Antiplatelet Therapy in Patients Treated for In-Stent Restenosis : A PRODIGY Trial Substudy (Prolonging Dual Antiplatelet Treatment After Grading Stent-Induced Intimal Hyperplasia)
Keywords: DES، استنت (ها) دارو،; dual antiplatelet therapy; aspirin; clopidogrel; in-stent restenosis; drug eluting stent(s); percutaneous coronary interventionCVA, cerebrovascular accident; DAPT, dual antiplatelet therapy; DES, drug-eluting stent(s); ISR, in-stent restenosis; MI, myocar
Short- and Long-Term Cause of Death in Patients Treated With Primary PCI for STEMI
Keywords: DES، استنت (ها) دارو،; acute myocardial infarction; cause of death; follow-up study; percutaneous coronary interventionAMI, acute myocardial infarction; BMS, bare-metal stent(s); CPR, civil personal registration (number); DES, drug-eluting stent(s); MODS, multiorgan dysfunction
The Absorb Bioresorbable Vascular Scaffold in Coronary Bifurcations : Insights From Bench Testing
Keywords: DES، استنت (ها) دارو،; bifurcation; bioresorbable vascular scaffold; kissing balloon inflation; stentingBVS, bioresorbable vascular scaffold(s); CT, computed tomography; DES, drug-eluting stent(s); FKB, final kissing balloon(s); OCT, optical coherence tomography; PCI, percutane
The EXAMINATION Trial (Everolimus-Eluting Stents Versus Bare-Metal Stents in ST-Segment Elevation Myocardial Infarction) : 2-Year Results From a Multicenter Randomized Controlled Trial
Keywords: DES، استنت (ها) دارو،; myocardial infarction; revascularization; stent(s); thrombosis; trialsBMS, bare-metal stent(s); DES, drug-eluting stent(s); EES, everolimus-eluting stent(s); STEMI, ST-segment elevation myocardial infarction